Literature DB >> 6455423

The effect of natural and synthetic D-fructose 2,6-bisphosphate on the regulatory kinetic properties of liver and muscle phosphofructokinases.

K Uyeda, E Furuya, L J Luby.   

Abstract

The effect of natural "activation factor" and synthetic fructose-2,6-P2 on the allosteric kinetic properties of liver and muscle phosphofructokinases was investigated. Both synthetic and natural fructose-2,6-P2 show identical effects on the allosteric kinetic properties of both enzymes. Fructose-2,6-P2 counteracts inhibition by ATP and citrate and decreases the Km for fructose-6-P. This fructose ester also acts synergistically with AMP in releasing ATP inhibition. The Km values of liver and muscle phosphofructokinase for fructose-2,6-P2 in the presence of 1.25 mM ATP are 12 milliunits/ml (or 24 nM) and 5 milliunits/ml (or 10 nM), respectively. At near physiological concentrations of ATP (3 mM) and fructose-6-P (0.2 mM), however, the Km values for fructose-2,6-P2 are increased to 12 microM and 0.8 microM for liver and muscle enzymes, respectively. Thus, fructose-2,6-P2 is the most potent activator of the enzyme compared to other known activators such as fructose-1,6-P2. The rates of the reaction catalyzed by the enzymes under the above conditions are nonlinear: the rates decelerate in the absence or in the presence of lower concentrations of fructose-2,6-P2, but the rates become linear in the presence of higher concentrations of fructose-2,6-P2. Fructose-2,6-P2 also protects phosphofructokinase against inactivation by heat. Fructose-2,6-P2, therefore, may be the most important allosteric effector in regulation of phosphofructokinase in liver as well as in other tissues.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6455423

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Upregulation of heart PFK-2/FBPase-2 isozyme in skeletal muscle after persistent contraction.

Authors:  Jordi Rovira; Jose Maria Irimia; Mario Guerrero; Joan Aureli Cadefau; Roser Cussó
Journal:  Pflugers Arch       Date:  2012-01-13       Impact factor: 3.657

2.  Analysis of Chinese hamster ovary cell metabolism through a combined computational and experimental approach.

Authors:  Ning Chen; Mark H Bennett; Cleo Kontoravdi
Journal:  Cytotechnology       Date:  2013-11-29       Impact factor: 2.058

Review 3.  Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.

Authors:  L Hue; M H Rider
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

4.  Hexose diphosphates and phosphofructokinase in rat brain during development.

Authors:  G J Dombrowski; K R Swiatek; K L Chao
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

5.  Regulation of fructose-6-phosphate 2-kinase by phosphorylation and dephosphorylation: possible mechanism for coordinated control of glycolysis and glycogenolysis.

Authors:  E Furuya; M Yokoyama; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  Central cavity of fructose-1,6-bisphosphatase and the evolution of AMP/fructose 2,6-bisphosphate synergism in eukaryotic organisms.

Authors:  Yang Gao; Lu Shen; Richard B Honzatko
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

7.  Fructose-2,6-P2, chemistry and biological function.

Authors:  K Uyeda; E Furuya; C S Richards; M Yokoyama
Journal:  Mol Cell Biochem       Date:  1982-10-18       Impact factor: 3.396

8.  A protein inhibitor of phosphofructokinase from the mucosa of rat small intestine. A mechanism for the regulation of glycolysis that is independent of glucose.

Authors:  G L Kellett; J P Robertson
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

9.  Evidence for a specific phosphoryl binding site in swine kidney phosphofructokinase.

Authors:  S Ashkar; K Muniyappa; F Leibach; J Mendicino
Journal:  Mol Cell Biochem       Date:  1984-04       Impact factor: 3.396

10.  Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinase.

Authors:  T Shimizu; N Kono; I Mineo; S Sumi; K Nonaka; S Tarui; W Koyama
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.